Ayahuasca: Pharmacology, neuroscience and therapeutic potential
- PMID: 26976063
- DOI: 10.1016/j.brainresbull.2016.03.002
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
Abstract
Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) from P. viridis, plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties from B. caapi. Acute administration induces a transient modified state of consciousness characterized by introspection, visions, enhanced emotions and recollection of personal memories. A growing body of evidence suggests that ayahuasca may be useful to treat substance use disorders, anxiety and depression. Here we review the pharmacology and neuroscience of ayahuasca, and the potential psychological mechanisms underlying its therapeutic potential. We discuss recent findings indicating that ayahuasca intake increases certain mindfulness facets related to acceptance and to the ability to take a detached view of one's own thoughts and emotions. Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality and substance use disorders and also in the handling of trauma. More research is needed to assess the full potential of ayahuasca in the treatment of these disorders.
Keywords: Ayahuasca; Beta-carbolines; DMT; Neuroscience; Pharmacology; Therapeutic potential.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.Psychopharmacology (Berl). 2016 Mar;233(5):823-9. doi: 10.1007/s00213-015-4162-0. Epub 2015 Nov 27. Psychopharmacology (Berl). 2016. PMID: 26612618
-
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902. Curr Neuropharmacol. 2019. PMID: 29366418 Free PMC article. Review.
-
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.Drug Test Anal. 2012 Jul-Aug;4(7-8):610-6. doi: 10.1002/dta.1344. Epub 2012 Apr 19. Drug Test Anal. 2012. PMID: 22514127
-
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.J Med Toxicol. 2017 Sep;13(3):245-248. doi: 10.1007/s13181-016-0593-1. Epub 2016 Nov 28. J Med Toxicol. 2017. PMID: 27896660 Free PMC article.
-
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.Biomolecules. 2022 Nov 2;12(11):1618. doi: 10.3390/biom12111618. Biomolecules. 2022. PMID: 36358968 Free PMC article. Review.
Cited by
-
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review.
-
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.Front Psychiatry. 2024 Jan 8;14:1302559. doi: 10.3389/fpsyt.2023.1302559. eCollection 2023. Front Psychiatry. 2024. PMID: 38264636 Free PMC article.
-
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.Front Pharmacol. 2023 Nov 27;14:1246892. doi: 10.3389/fphar.2023.1246892. eCollection 2023. Front Pharmacol. 2023. PMID: 38089057 Free PMC article.
-
Psychological and physiological effects of extended DMT.J Psychopharmacol. 2024 Jan;38(1):56-67. doi: 10.1177/02698811231196877. Epub 2023 Oct 28. J Psychopharmacol. 2024. PMID: 37897244 Free PMC article. Clinical Trial.
-
A Systematic Review on the Therapeutic Effects of Ayahuasca.Plants (Basel). 2023 Jul 7;12(13):2573. doi: 10.3390/plants12132573. Plants (Basel). 2023. PMID: 37447135 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources